The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2020 | Impact of the COVID-19 pandemic on multiple myeloma treatment
Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, outlines the impact of the COVID-19 pandemic on the treatment of patients with multiple myeloma. Dr Ghobrial discusses the benefits and limitations of telemedicine on patient care and how this could affect therapeutic approaches in the future. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.
